Upscaling and Risk Evaluation of the Synthesis of the 3,5-Diamino-1H-Pyrazole, Disperazol
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Forlagets udgivne version, 1,17 MB, PDF-dokument
This paper presents the work performed to transition a lab-scale synthesis (1 g) to a large-scale (400 g) synthesis of the 3-5-diamino-1H-Pyrazole Disperazol, a new pharmaceutical for treatment of antibiotic-resistant Pseudomonas aeruginosa biofilm infections. The potentially hazardous diazotisation step in the lab-scale synthesis was transformed to a safe and easy-to-handle flow chemistry step. Additionally, the paper presents an OSHA-recommended safety assessment of active compound E, as performed by Fauske and Associates, LLC, Burr Ridge, IL, USA.
Originalsprog | Engelsk |
---|---|
Artikelnummer | 6737 |
Tidsskrift | International Journal of Molecular Sciences |
Vol/bind | 25 |
Udgave nummer | 12 |
Antal sider | 8 |
ISSN | 1661-6596 |
DOI | |
Status | Udgivet - 2024 |
Bibliografisk note
Publisher Copyright:
© 2024 by the authors.
ID: 398072077